Skip to main content
Viatris Inc logo

Viatris Inc — Investor Relations & Filings

Ticker · VTRS ISIN · US92556V1061 LEI · 254900ZZTSW7NL773X71 US Manufacturing
Filings indexed 489 across all filing types
Latest filing 2026-05-15 Regulatory Filings
Country US United States of America
Listing US VTRS

About Viatris Inc

https://www.viatris.com/en

Viatris Inc. is a global healthcare company focused on empowering people to live healthier at every stage of life. The company operates by bridging the divide between generic and branded medicines, combining aspects of both to enhance patient access worldwide. Its portfolio comprises a wide range of high-quality medicines, including oral solid doses, injectables, complex dosage forms, and active pharmaceutical ingredients (APIs). These products cover numerous therapeutic areas, addressing both noncommunicable and infectious diseases. Viatris's offerings treat many of the World Health Organization's leading causes of death. The company continues to expand its capabilities, including recent acquisitions to strengthen its presence in the central nervous system (CNS) therapeutic area.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings
2026-05-15 English
10-Q - Viatris Inc (0001792044) (Filer)
Interim / Quarterly Report
2026-05-07 English
8-K - Viatris Inc (0001792044) (Filer)
Regulatory Filings
2026-05-07 English
8-K - Viatris Inc (0001792044) (Filer)
Regulatory Filings
2026-05-04 English
ARS - Viatris Inc (0001792044) (Filer)
Annual Report
2026-04-02 English
SCHEDULE 13G/A - Viatris Inc (0001792044) (Subject)
Major Shareholding Notification
2026-03-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.